Hot Biotech Events for Next Week: BioBuzz
Investor conferences and phase III data on tap for post-Labor Day
07:50AM 09/04/09
Don't Get Burned by the Next Cell Genesys
Senior Columnist Adam Feuerstein re-examines the red flags in the Cell Genesys story so that when the same issues rear their ugly head in another biotech story investors will be better prepared.
10:00AM 10/20/08
Feuerstein's Biotech-Stock Mailbag
Glaxo may face a tough sell with newly approved Treximet; additional feedback on Elan, and more.
09:00AM 04/19/08
Feuerstein's Biotech-Stock Mailbag
A health stock rebound? Plus, my take on Onyx and M&A speculation fun.
11:41AM 04/05/08
Tuesday's Health Winners & Losers
PDL BioPharma helped boost health care stocks Tuesday.
04:41PM 08/21/07
These Gene-Drug Stocks Are Getting Hot
A Nobel Prize has stoked the fire in a hot biotech sector.
06:14AM 07/12/07
Pharmacyclics Needs a Fair Shake
The FDA's handling of the company's cancer drug doesn't fit the Dendreon-driven environment.
10:05PM 05/02/07
As the Dow hits a new high, money manager Ken Fisher explains why stocks will keep rallying in '07.
05:42PM 12/15/06
Friday's Health Winners & Losers
Genta plunges as regulators say its cancer treatment is not approvable.
01:55PM 12/15/06
Regulators say its proposed blood cancer treatment Genasense isn't approvable.
10:59AM 12/15/06
Friday's Health Care Winners & Losers
Chattem jumps on consumer-products purchase from Johnson & Johnson.
01:08PM 10/06/06
The FDA agrees to the design of a proposed trial for an experimental leukemia treatment.
10:47AM 10/06/06



Connect with TheStreet